Evidence map›Paper›PMID 39324378›Full record

ArticleEuropean journal of pain (London, England)2025

Geographical disparities in fibromyalgia severity: An Italian study.

Marco Di Carlo, Sonia Farah, Fabiola Atzeni, Alessandra Alciati, Manuela Di Franco, Cristina Iannuccelli, Laura Bazzichi, Gerolamo Bianchi, Massimo Giovale, Rosella Tirri and 14 more

Abstract read
In one paragraph

Article in European journal of pain (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Geographical disparities in fibromyalgia severity: An Italian study.European journal of pain (London, England) · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marco Di CarloRheumatology Unit, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica Delle Marche, Ancona, Italy.ORCID https://orcid.org/0000-0002-0906-4647
Sonia FarahRheumatology Unit, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica Delle Marche, Ancona, Italy.ORCID https://orcid.org/0000-0002-9815-2621
Fabiola AtzeniRheumatology Unit, Department of Internal Medicine, University of Messina, Messina, Italy.ORCID https://orcid.org/0000-0002-9328-3075
Alessandra AlciatiDepartment of Clinical Neurosciences, Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, Como, and Humanitas Clinical and Research Centre, Milan, Italy.ORCID https://orcid.org/0000-0002-8971-4696
Manuela Di FrancoRheumatology Unit, Department of Internal Clinical, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Cristina IannuccelliRheumatology Unit, Department of Internal Clinical, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0003-1428-9725
Laura BazzichiRheumatology Unit, AOU Pisana, Pisa, Italy.
Gerolamo BianchiDivision of Rheumatology, La Colletta Hospital, Arenzano, Italy.
Massimo GiovaleDivision of Rheumatology, La Colletta Hospital, Arenzano, Italy.
Rosella TirriDipartimento di Medicina di Precisione, Reumatologia, Università Degli Studi Della Campania L.Vanvitelli, Naples, Italy.
Serena GuiducciDivisions of Internal Medicine and Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Giuliana GugginoDepartment of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Franco FranceschiniUnit of Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy.
Rosario FotiAzienda Ospedaliera Universitaria Policlinico San Marco, Catania, Italy.
Alberto Lo GulloAzienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi, Catania, Italy.
Giovanni BiasiRheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Elisa GremeseUOC Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Enrico TirriASL Napoli 1, Centro Ospedale San Giovanni Bosco, Naples, Italy.
Roberto GiacomelliUnit of Allergology, Clinical Immunology and Rheumatology, Università Campus Bio-Medico di Roma, Rome, Italy.
Alberto BatticiottoASST Sette Laghi, Varese, Italy.
Maurizio CutoloResearch Laboratory and Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino, Genoa, Italy.
Piercarlo Sarzi-PuttiniRheumatology Unit, IRCCS Ospedale Galeazzi-S. Ambrogio, Università Degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0002-8673-5133
Fausto SalaffiRheumatology Unit, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica Delle Marche, Ancona, Italy.ORCID https://orcid.org/0000-0002-3794-6831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGeographic origin may represent a variable capable of influencing health status. This study aims to investigate the presence of differences of disease severity in Italian patients with fibromyalgia from different macro-regions.

methodsThis retrospective, cross-sectional study involved patients included in the Italian Fibromyalgia Registry. Three geographical macro-regions were identified, comprising patients from Northern Italy, Central Italy and Southern Italy. Clinical differences (evaluated through PolySymptomatic Distress Scale [PSD], revised Fibromyalgia Impact Questionnaire [FIQR] and modified Fibromyalgia Assessment Status [FASmod]) among the geographical macro-regions were studied using one-way analysis of variance (ANOVA) and the Scheffé's test.

resultsA total of 6095 patients (5719 females and 376 males) were included, with 1957 from Northern Italy, 2979 from Central Italy and 1159 from Southern Italy. All studied clinical indices showed a trend indicative of greater disease severity in Southern Italy, followed by Northern Italy and then Central Italy (mean values for PSD: 19.97 ± 6.20 in Northern Italy, 18.61 ± 7.12 in Central Italy, 23.01 ± 5.66 in Souther Italy). These differences were statistically significant for the overall scores of all studied indices, evaluated with ANOVA (all p < 0.001) and in the head to head comparisons, evaluted with Scheffé's test.

conclusionsGeographic background is significantly associated with variations in the severity of fibromyalgia in Italian patients. SIGNIFICANCE STATEMENT: This is the first study to demonstrate geographical origin-dependent intra-national differences in the severity of fibromyalgia. The results confirm the necessity of considering fibromyalgia within the context of the biopsychosocial model and of implementing healthcare policies targeted towards the most underserved regions.

Indexed as

FibromyalgiaAdultAgedCross-Sectional StudiesFemaleHumansItalyMaleMiddle AgedRegistriesRetrospective StudiesSeverity of Illness Index

Identifiers

PMID39324378
PMCPMC11755690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.